NASDAQ:AXON

Axon Enterprise Stock Forecast, Price & News

$148.22
-1.20 (-0.80 %)
(As of 04/12/2021 03:27 PM ET)
Add
Compare
Today's Range
$145.88
Now: $148.22
$149.70
50-Day Range
$133.45
MA: $150.59
$177.00
52-Week Range
$65.50
Now: $148.22
$212.37
Volume4,035 shs
Average Volume647,169 shs
Market Capitalization$9.59 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.21
Axon Enterprise, Inc. engages in the development, manufacturing, and sale of conducted electrical weapons for personal defense. It operates through the TASER Weapons and Software and Sensors segments. The TASER Weapons segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Axon Enterprise logo

Industry, Sector and Symbol

Industry Security Software & Services
Sub-IndustrySystems Software
Current SymbolNASDAQ:AXON
CUSIPN/A
Phone(480) 991-0797
Employees1,323
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.19 per share

Profitability

Net Income$-221,570,000.00

Miscellaneous

Market Cap$9.59 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

Headlines

Drones Could Drive More Growth for Axon
March 15, 2021 |  nasdaq.com
Why Axon Enterprise Stock Rose Today
March 11, 2021 |  fool.com
Is Axon Enterprise (AXON) A Smart Long-Term Buy?
March 9, 2021 |  finance.yahoo.com
AXON Jun 2021 170.000 call
March 8, 2021 |  uk.finance.yahoo.com
Axon Enterprise EPS beats by $0.64, beats on revenue
February 27, 2021 |  seekingalpha.com
See More Headlines

MarketRank

Overall MarketRank

1.29 out of 5 stars

Technology Services Sector

1st out of 26 stocks

Security Software & Services Industry

1st out of 2 stocks

Analyst Opinion: 3.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$148.22
-1.20 (-0.80 %)
(As of 04/12/2021 03:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AXON News and Ratings via Email

Sign-up to receive the latest news and ratings for AXON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Axon Enterprise (NASDAQ:AXON) Frequently Asked Questions

Is Axon Enterprise a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Axon Enterprise stock.
View analyst ratings for Axon Enterprise
or view top-rated stocks.

What stocks does MarketBeat like better than Axon Enterprise?

Wall Street analysts have given Axon Enterprise a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Axon Enterprise wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Axon Enterprise?

Axon Enterprise saw a decline in short interest in February. As of February 26th, there was short interest totaling 1,660,000 shares, a decline of 22.4% from the February 11th total of 2,140,000 shares. Based on an average daily volume of 686,400 shares, the short-interest ratio is currently 2.4 days. Currently, 2.7% of the company's shares are short sold.
View Axon Enterprise's Short Interest
.

When is Axon Enterprise's next earnings date?

Axon Enterprise is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Axon Enterprise
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) issued its quarterly earnings data on Wednesday, February, 24th. The biotechnology company reported $1.00 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.64.
View Axon Enterprise's earnings history
.

How has Axon Enterprise's stock price been impacted by Coronavirus?

Axon Enterprise's stock was trading at $2.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, AXON shares have increased by 5,182.6% and is now trading at $148.97.
View which stocks have been most impacted by COVID-19
.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2021 After-Hours earnings guidance on Thursday, February, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $740-780 million, compared to the consensus revenue estimate of $742.24 million.

What price target have analysts set for AXON?

5 brokerages have issued 12 month target prices for Axon Enterprise's shares. Their forecasts range from $170.00 to $200.00. On average, they expect Axon Enterprise's stock price to reach $183.50 in the next year. This suggests a possible upside of 23.2% from the stock's current price.
View analysts' price targets for Axon Enterprise
or view top-rated stocks among Wall Street analysts.

Who are Axon Enterprise's key executives?

Axon Enterprise's management team includes the following people:
  • Patrick W. Smith, Chief Executive Officer & Director
  • Luke S. Larson, President
  • Josh Goldman, Senior Vice President-Operations
  • Jawad A. Ahsan, Chief Financial Officer
  • Jenner Holden, Chief Information Security Officer

Who are some of Axon Enterprise's key competitors?

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), (CGC), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an IPO on Thursday, June 11th 2015. The company issued 17,900,000 shares at $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

How do I buy shares of Axon Enterprise?

Shares of AXON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $148.97.

How much money does Axon Enterprise make?

Axon Enterprise has a market capitalization of $9.63 billion. The biotechnology company earns $-221,570,000.00 in net income (profit) each year or ($2.06) on an earnings per share basis.

How many employees does Axon Enterprise have?

Axon Enterprise employs 1,323 workers across the globe.

What is Axon Enterprise's official website?

The official website for Axon Enterprise is www.axovant.com.

Where are Axon Enterprise's headquarters?

Axon Enterprise is headquartered at 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company can be reached via phone at (480) 991-0797.


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.